Fulcrum Therapeutics (FULC) Q4 2025 Earnings

29OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.31
-0.3
-0.29
-0.28

Details

Expected EPS
-0.29375
Actual EPS
-0.31
Surprise EPS
-0.02
Surprise Percent
+5.53%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.31 per share for Q4 2025.

0 Comments

Share your thoughts